TCWM
ABBV icon

Total Clarity Wealth Management’s AbbVie ABBV Stock Holding History

Total Clarity Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Buy
7,072
+254
+4% +$54.6K 0.35% 74
2026
Q1 		$1.48M Buy
6,818
+159
+2% +$35.3K 0.35% 75
2025
Q4 		$1.52M Sell
6,659
-28
-0.4% -$6.38K 0.37% 78
2025
Q3 		$1.55M Sell
6,687
-57
-0.8% -$11.6K 0.41% 64
2025
Q2 		$1.25M Buy
6,744
+734
+12% +$136K 0.36% 76
2025
Q1 		$1.07M Hold
6,010
– – 0.35% 76
2024
Q4 		$1.07M Sell
6,010
-135
-2% -$24.8K 0.35% 77
2024
Q3 		$1.21M Buy
6,145
+222
+4% +$41.4K 0.39% 68
2024
Q2 		$1.02M Buy
5,923
+35
+0.6% +$5.8K 0.35% 76
2024
Q1 		$1.07M Buy
5,888
+476
+9% +$82K 0.37% 79
2023
Q4 		$839K Sell
5,412
-1,066
-16% -$155K 0.34% 88
2023
Q3 		$966K Buy
6,478
+60
+0.9% +$8.81K 0.46% 60
2023
Q2 		$865K Sell
6,418
-613
-9% -$89.9K 0.43% 69
2023
Q1 		$1.12M Sell
7,031
-29
-0.4% -$4.43K 0.61% 48
2022
Q4 		$1.14M Buy
7,060
+452
+7% +$69.3K 0.58% 41
2022
Q3 		$887K Buy
6,608
+78
+1% +$11.2K 0.55% 52
2022
Q2 		$1M Buy
6,530
+64
+1% +$9.78K 0.52% 48
2022
Q1 		$1.05M Sell
6,466
-86
-1% -$12.5K 0.57% 51
2021
Q4 		$887K Buy
6,552
+519
+9% +$61.3K 0.4% 65
2021
Q3 		$651K Buy
6,033
+189
+3% +$21.6K 0.31% 83
2021
Q2 		$658K Buy
5,844
+247
+4% +$27.8K 0.37% 82
2021
Q1 		$606K Sell
5,597
-34
-0.6% -$3.64K 0.35% 68
2020
Q4 		$603K Sell
5,631
-159
-3% -$15.3K 0.42% 66
2020
Q3 		$507K Sell
5,790
-249
-4% -$23.4K 0.44% 61
2020
Q2 		$593K Buy
6,039
+63
+1% +$5.55K 0.54% 52
2020
Q1 		$455K Buy
5,976
+882
+17% +$75.1K 0.7% 48
2019
Q4 		$451K Buy
+5,094
New +$423K 0.34% 66

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Total Clarity Wealth Management's ABBV Position: Q2 2026 in Review

Total Clarity Wealth Management increased its AbbVie (ABBV) stake by 3.7% in Q2 2026, buying an estimated $54.6K and bringing the position to 7,072 shares worth $1.78M. The position accounts for 0.35% of the portfolio, ranked #74.

Total Clarity Wealth Management first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Total Clarity Wealth Management held 7,072 shares of AbbVie worth $1.78M as of Q2 2026.
  • Total Clarity Wealth Management bought 254 AbbVie shares in Q2 2026, an estimated $54.6K.
  • AbbVie made up 0.35% of Total Clarity Wealth Management's portfolio in Q2 2026, its #74 holding.
  • Total Clarity Wealth Management first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Total Clarity Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.